Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  02/27/2008
 
Trade Name:  Nexium
 
Generic Name or Proper Name (*):  esomeprazole
 
Indications Studied:  Short-term treatment of GERD
 
Label Changes Summary:  * Expanded age range to include pediatric patients 1-11 years. Previously approved in 12-17 years * Use in pediatric patients 1 to 17 years of age is supported by extrapolation from studies in adults, and safety and PK studies performed in pediatric and adolescent patients * Safety and effectiveness in pediatric patients <1 year of age have not been established * Safety and effectiveness for other pediatric uses have not been established * Information on dose, treatment related adverse events (AEs), clinical study * New formulation
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B):  B
 
Sponsor:  AstraZeneca
 
Pediatric Exclusivity Granted Date:  05/01/2009
 
NNPS:  FALSE
 
Therapeutic Category:  Antiulcerative
 
-
-